OpenAlex
PricingAboutJobs
Log inGet started
Work

PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer

HTML

Year: 2014
Type: review
Source: Pharmacology & Therapeutics
DOI: 10.1016/j.pharmthera.2014.10.003
Authors: Anindita Das, David Durrant, Fadi N. Salloum, Lei Xi, Rakesh C. Kukreja
Institutions: Virginia Commonwealth University, Virginia Commonwealth University Medical Center
Language: English

Topic: Phosphodiesterase function and regulation
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: green

Funders: Foundation for the National Institutes of Health, American Heart Association, National Institutes of Health, National Heart, Lung, and Blood Institute
Awards: G1004564342, G1687339285, Molecular Mechanisms of Delayed Preconditioning, Cardioprotective Signaling following Phosphodiesterase-5 Inhibition, G3348589736, G4245952639, Cardioprotective Effects of PDE-5 Inhibitors, Protection against Doxorubicin-Induced Cardiomyopathy, G5702023534, ROS, Inflammation, and Cardioprotection in Type 2 Diabetes
OpenAlex ID: W2070737114
FWCI: 2.039
Cites: 146
Cited by: 216
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms